Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Shortages and supply disruptions (16)
- Safety monitoring and information (125)
- Compliance and enforcement (33)
- Import and export (30)
- Sunscreens (9)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
808 result(s) found, displaying 651 to 675
-
Safety alerts
-
-
Market actionsWe are recalling all batches of Muscletech Hydroxystim capsules due to the presence of the banned substance DMAA. Consult your doctor if you have concerns.
-
Market actionsSix batches of Infanrix hexa vaccine are being recalled due to potential contamination with Bacillus cereus. Consult your doctor if you have concerns.
-
Safety alerts
-
Market actionsSome batches of the Typhim Vi Vaccine are being recalled due to lower antigen content. Consult your doctor if you have concerns.
-
Safety alerts
-
-
Market actionsWe are recalling Serenace (haloperidol) 0.5mg tablets from batch BJ431 due to mould contamination. Consult your doctor if you have concerns.
-
Safety alertsPoly Implant Prothèse (PIP) update
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
-
Safety alerts
-
-
-
-
-
Safety alertsBackground information for consumers about Poly Implant Prothèse (PIP) breast implants
-
-
Market actionsThe Therapeutic Goods Administration (TGA) advises that the R3 metal liner component of the R3 acetabular system (used in hip replacements) is being recalled by the Australian sponsor, Smith & Nephew Surgical Pty Ltd.
-
-
-